Position in ECOR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$50,790
+$17,328 QoQ
Shares Held
8,423
+12.9% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ECOR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026UBS Group AG holds $5,241,938,219 across 132 Medical Devices names. ECOR ranks #97 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
12,152,765 | $1,247,724,380 | |
| 2 | BSX |
Boston Scientific Corp
|
14,824,662 | $930,247,536 | |
| 3 | MDT |
Medtronic plc
|
6,412,252 | $555,621,633 | |
| 4 | SYK |
Stryker Corp
|
1,646,714 | $541,093,748 | |
| 5 | DXCM |
Dexcom Inc
|
4,349,959 | $273,177,422 | |
| 6 | EW |
Edwards Lifesciences Corp
|
2,561,776 | $205,147,019 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
2,805,315 | $199,682,320 | |
| 8 | PEN |
Penumbra Inc
|
560,335 | $183,997,200 |
All Filings in ECOR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $50,790 | 8,423 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $33,462 | 7,461 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $38,649 | 7,808 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $47,403 | 8,978 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $36,600 | 5,471 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $12,853 | 793 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $12,216 | 1,692 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,693 | 1,663 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $163 | 27 | Shares | Sole | 2023-11-09 | |
| 2023-03-31 | $4,746 | 863 | Shares | Defined | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||